Evolution of the Average Target: IMPACT Therapeutics, Inc

Evolution of the Target Price: IMPACT Therapeutics, Inc

Changes in Analyst Recommendations: IMPACT Therapeutics, Inc

5bc9b5a76312.a-62mJzCXT09-AejUENSkMOvZOr3jHpesiCF-WeKXWg.H5T47NaxKUdNz3LtOBYxoq7DK9KA1QMs2m3joSbhCiQ4jc_qsYxvaHeKPw~431f857631292c7102d503e594344219

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- - - - +156.64%
+21.25%
+4.92%
+16.57%
+29.09%
+39.1%
-1.01%
+26.11%
+4.09%
+13.49%
Average +31.03%
Weighted average by Cap. +18.95%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
10.34CNY
Average target price
28.52CNY
Spread / Average Target
+175.90%
High Price Target
28.52CNY
Spread / Highest target
+175.90%
Low Price Target
28.52CNY
Spread / Lowest Target
+175.90%

Analyst Consensus Detail

Consensus revision (last 18 months)

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
10.34CNY
Average target price
28.52CNY
Spread / Average Target
+175.90%

Net sales - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 7630 Stock
  4. Consensus IMPACT Therapeutics, Inc